MedTrace Logo

Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin

NCT06620744 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-06-05

No results posted yet for this study

Summary

This prospective device study will examine the feasibility of MCG data collection in a hospital setting using the SandboxAQ MCG device as a potential method to more accurately and quickly quantify cardiac disease of patients with elevated Troponin.

Conditions

  • ACS - Acute Coronary Syndrome

Interventions

DEVICE

Sponsor MCG deivce

Unshielded device measuring cardiac magnetic fields.

Sponsors & Collaborators

  • SB Technology, Inc.

    lead INDUSTRY

Principal Investigators

  • Kit Yee Au-Yeung, PhD · SB Technology, Inc.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-21
Primary Completion
2025-04-15
Completion
2025-04-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06620744 on ClinicalTrials.gov